GLP-1 receptor agonist medications as a class have become an important class of medications for managing type 2 diabetes and obesity, offering benefits such as improved glycemic control, weight loss, low risk of hypoglycemia and improved cardiovascular health. The gene discussed is GLP1R; the disease is obesity disorder.